Drug exposure and flow cytometry analyses in a thalidomide treatment schedule that prolongs rat cardiac graft survival
Eriksson, T.; Riesbeck, K.; Ostraat, O.; Ekberg, H.; Björkman, S.
Transplantation Proceedings 24(6): 2560-2561
1992
ISSN/ISBN: 0041-1345 PMID: 1465866 Document Number: 388778
Document emailed within 1 workday
Related Documents
Donaldson, P.T.; Thomson, L.J.; Heads, A.; Underhill, J.A.; Vaughan, R.W.; Rolando, N.; Williams, R. 1995: IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry Transplantation 60(9): 1016-1023Rehman, A.; Tu, Y.; Flye, M.W. 1996: Combined CTLA4Ig and anti-CD4/DC8 monoclonal antibody treatment prolongs survival of rat-to-mouse heterotopic cardiac xenografts Transplantation Proceedings 28(2): 660-661
Henry, M.L.; Bendle, M.D. 1996: Donor graft perfusion pre-transplant prolongs xenograft survival Transplantation Proceedings 28(2): 595
Orlowski, J.P.; Spees, E.K. 1993: Improved cardiac transplant survival with thyroxine treatment of hemodynamically unstable donors: 95.2% graft survival at 6 and 30 months Transplantation Proceedings 25(1 Part 2): 1535
Lussow, A.R.; Fanget, L.; Gao, L.; Buelow, R.; Pouletty, P. 1996: Targeting of activated T-cells with natural cytotoxic antibodies via an IL2-hapten conjugate prolongs graft survival Transplantation Proceedings 28(2): 571-572
Lesnikoski, B.A.; Candinas, D.; Hancock, W.W.; Otsu, I.; Siegel, J.; Bach, F.H.; Robson, S.C. 1996: Inhibition of platelet GPIIbIIIa prolongs survival of discordant cardiac xenografts Transplantation Proceedings 28(2): 703
Mazzini, G.; Ferrari, C.; Erba, E. 2003: Dual excitation multi- fluorescence flow cytometry for detailed analyses of viability and apoptotic cell transition European Journal of Histochemistry: Ejh 47(4): 289-298
Hayashida, M. 2015: Application of Flow Cytometry in Clinical Laboratories and its Future Direction, Focusing Upon Multicolor Flow Cytometry Rinsho Byori. Japanese Journal of Clinical Pathology 63(7): 832-840
Stephenson, R.A.; James, B.C.; Gay, H.; Fair, W.R.; Whitmore, W.F.; Melamed, M.R. 1987: Flow cytometry of prostate cancer: relationship of DNA content to survival Cancer Research 47(9): 2504-2507
Xia, J.; Jiang, X.; Huang, Y.; Zhang, K.; Xiao, S.; Yang, C. 2003: Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation Chinese Medical Journal 116(3): 432-435
Russo, V.; Barker-Gear, R.; Gates, R.; Franco, R. 1992: Studies with biotinylated RBC: (1) use of flow cytometry to determine posttransfusion survival and (2) isolation using streptavidin conjugated magnetic beads Advances in Experimental Medicine and Biology 326: 101-107
Volm, M.; Mattern, J.; Müller, T.; Drings, P. 1988: Flow cytometry of epidermoid lung carcinomas: relationship of ploidy and cell cycle phases to survival. a five-year follow up study Anticancer Research 8(1): 105-112
Gao, Z.; Gao, Z.; Wang, F. 1996: Analysis of changes in human embryo fibroblasts with long-term exposure to drinking water in gastric cancer prevalent areas by flow cytometry Zhonghua Yu Fang Yi Xue Za Zhi 30(4): 199-201
Tchervenkov, J.I.; Epstein, M.D.; Alexander, J.W.; Schroeder, T.J. 1989: The effect of donor-specific blood transfusion, cyclosporine, and dietary prostaglandin precursors on rat cardiac allograft survival. II. Effectiveness of a 24-hour induction period with DST and CsA in inducing long-term graft survival Transplantation 47(1): 177-181
Greig, P.D.; Woolf, G.M.; Abecassis, M.; Strasberg, S.M.; Taylor, B.; Superina, R.A.; Langer, B.; Glynn, M.F.; Ettles, M.; Blendis, L. 1989: Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival Transplantation Proceedings 21(1 Part 2): 2385-2388
Mirisklavos, A.; Mottram, P.L.; Smith, J.A.; Mason, A.; Dumble, L.J.; Clunie, G.J.; Panagiotopoulos, S.; Nayler, W.G. 1987: Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts Transplantation Proceedings 19(1 Part 2): 1259-1261
Fabian, M.A.; Canada, A.T.; Coleman, L.R.; Bollinger, R.R. 1992: Use of tissue blood flow and high energy phosphate content to predict small bowel graft survival Transplantation Proceedings 24(3): 1088-1089
Hemmer, J.; Kreidler, J.; Kraft, K.; Schön, E. 1994: Monitoring of anticancer drug effects in vivo by serial DNA flow cytometry of oral carcinomas treated by intra-arterial 5-fluorouracil/cisplatin induction chemotherapy Anticancer Research 14(5b): 2077-2083
Hall, B.M.; Roser, B.J.; Dorsch, S.E. 1979: A model for study of the cellular mechanisms that maintain long-term enhancement of cardiac graft survival Transplantation Proceedings 11(1): 958-961
Fukuhara, T.; Miyake, T.; Maekawa, I.; Kurosawa, M.; Suzuki, S.; Noto, S.; Mori, A.; Chiba, K.; Toyoshima, T.; Hirano, T.; Morioka, M.; Tsutsumi, Y.; Okabe, M.; Kakinoki, Y. 2000: Treatment with low-dose cytosine arabinoside followed by administration of macrophage colony-stimulating factor prolongs the survival of patients with RAEB, RAEB-T, or leukemic phase myelodysplastic syndrome: a pilot study International Journal of Hematology 71(4): 366-371